Jakarta (ANTARA News) - Indonesia still imports over 90 percent of the pharmaceutical raw materials it needs, showing that its dependence on overseas industries is very high, a pharmaceutical traders spokesman said.
"And some 70 percent of the imported raw materials come from China," Kendrariadi Suhanda, deputy secretary general of the Indonesian Pharmacies Association (GPFI) told the press on the occasion of `Indo Medica Expo 2008` here on Thursday.
He said Indonesia was predicted to become increasingly dependent on imports from China because the latter was continuously increasing the number of its raw material pharmaceutical industries and to improve the quality of their products.
"European countries whose pharmaceutical industries are advanced have begun to establish alliances with Chinese pharmaceutical raw material industries," he said.
He said Indonesia still lacked strong industries in the production of pharmaceutical raw materials. "This is home work for Indonesia."
Suhanda said the cost of research and development of a molecule of one pharmaceutical raw material could be as high as 250 - 500 million dollars.
"What Indonesia has to do now is establishing an alliance with Chinese pharmaceutical raw material producers," he said.
The value of the pharmaceutical raw material market in Indonesia at present was estimated at 2.5 billion US dollars, that in the Philippines 1.5 billion dollars, in Thailand one billion dollars and in Vietnam 600 million dollars, he said. (*)